glp-1 weight loss drug marketplace florida changes 2025 Market Size, Share Unpacking $100B+ Obesity Market Opportunity:

For analysts, this affects three basic metrics: Initiation : who can start treatment when the monthly cost is high

As GLP-1R agonists mediate their appetite-reducing effects within the central nervous system, the trafficking phenotype of exendin-phe1 could result in reduced brain penetration, mitigating against presumed advantageous effects on neuronal GLP-1R desensitization

By lowering blood sugar, the GLP-1 drugs can help protect the kidneys from this detrimental effect, which may delay or prevent kidney disease and kidney failure

[cited 2025 Feb 1]

However, they represent the most common reason for treatment discontinuation in clinical trials of GLP-1 receptor agonists